Clinical trial
Effect of, OAT3, on the Renal Secretion of Cefotaxime
NCT00187655 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00187655 |
|---|---|
| Title | Effect of, OAT3, on the Renal Secretion of Cefotaxime |
| Official title | Effect of Genetic Variation in the Transporter, OAT3, on the Renal Secretion of Cefotaxime |
| Lead sponsor | University of California, San Francisco, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Focus Groups |
| Intervention type | Drug |
| Interventions | Cefotaxime |
| Enrollment | 24 |
| Start date | Jan 1, 2004 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2013 |
| First posted | Sep 16, 2005 |
| Last update posted | Oct 29, 2014 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: